Skip to search.
 FTSE 100 Up 0.26%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
26.22 Up 1.96(8.08%) 22 May 21:00
|After Hours: : 26.17 Down 0.05 (0.19%) 23 May 00:51
Add to Portfolio
Prev Close:24.26
Open:25.11
Bid:26.15 x 1000
Ask:26.17 x 100
1y Target Est:29.94
Beta:1.2
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:25.00 - 26.98
52wk Range:11.33 - 35.43
Volume:3,891,557
Avg Vol (3m):1,362,600
Market Cap:1.09b
P/E (ttm):N/A
EPS (ttm):-4.13
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTUp 8.08%1.09b
ALNYDown 0.06%10.52b
GSKDown 0.66%109.30b
ISISUp 0.88%8.11b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):274.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.89
Quarterly EPS Est (Jun-15) :-1.21
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):26.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback